SB-242,084

SB-242,084
(IUPAC) ime
	6-hloro-5-metil-N-{6-[(2-metilpiridin-3-il)oksi]piridin-3-il]indolin-1-karboksamid
Klinički podaci
Identifikatori
CAS broj	181632-25-7
ATC kod	nije dodeljen
PubChem	3644637
ChEMBL	CHEMBL14563
Hemijski podaci
Formula	C21H19ClN4O2
Mol. masa	394,853 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C21H19ClN4O2/c1-13-10-15-7-9-26(18(15)11-17(13)22)21(27)25-16-5-6-20(24-12-16)28-19-4-3-8-23-14(19)2/h3-6,8,10-12H,7,9H2,1-2H3,(H,25,27) ; Key: GIUZEIJUFOPTMR-UHFFFAOYSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

Verzija za štampanje više nije podržana i može davati greške. Podnovite oznake i koristite ugrađenu mogućnost štampanja preglednika.

SB-242,084 je psihoaktivni lek i istraživačka hemikalija koja deluje kao selektivni antagonist za 5HT_2C receptor.^[4] On ima anksiolitičko dejstvo,^[5] i pojačava dopaminsku signalizaciju u limbičnom sistemu.^[6] On takođe ima kompleksno dejstvo na otpuštanje dopamina proizvedeno kokainom, povećavajući ga u pojedinim delovima mozga^[7]^[8] i snižavajući ga u drugim.^[9]^[10] Pokazano je da povišava efektivnost selektivnih inhibitora preuzimanja serotonina (SSRI), i da redukuje njihove nuspojave.^[11]^[12] U životinjskim studijama, SB-242,084 proizvodi stimulansnu aktivnost, koja je donekle slična ali znatno slabija od kokaina i amfetamina.^[13]

Povezano

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ Kennett, GA; Wood, MD; Bright, F; Trail, B; Riley, G; Holland, V; Avenell, KY; Stean, T i dr.. (1997). „SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist”. Neuropharmacology 36 (4–5): 609–20. DOI:10.1016/S0028-3908(97)00038-5. PMID 9225286.
↑ Martin, JR; Ballard, TM; Higgins, GA (2002). „Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety”. Pharmacology, Biochemistry, and Behavior 71 (4): 615–25. DOI:10.1016/S0091-3057(01)00713-4. PMID 11888553.
↑ Di Matteo, V; Di Giovanni, G; Di Mascio, M; Esposito, E (1999). „SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system”. Neuropharmacology 38 (8): 1195–205. DOI:10.1016/S0028-3908(99)00047-7. PMID 10462132.
↑ Navailles, S; De Deurwaerdère, P; Porras, G; Spampinato, U (2004). „In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum”. Neuropsychopharmacology 29 (2): 319–26. DOI:10.1038/sj.npp.1300329. PMID 14560323.
↑ Navailles, S; Moison, D; Ryczko, D; Spampinato, U (2006). „Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors”. Journal of Neurochemistry 99 (4): 1311–9. DOI:10.1111/j.1471-4159.2006.04188.x. PMID 17018023.
↑ Navailles, S; Moison, D; Cunningham, KA; Spampinato, U (2008). „Differential regulation of the mesoaccumbens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine”. Neuropsychopharmacology 33 (2): 237–46. DOI:10.1038/sj.npp.1301414. PMID 17429406.
↑ Leggio, GM; Cathala, A; Moison, D; Cunningham, KA; Piazza, PV; Spampinato, U (2009). „Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens”. Neuropharmacology 56 (2): 507–13. DOI:10.1016/j.neuropharm.2008.10.005. PMC 3130963. PMID 18977370.
↑ Cremers, TI; Giorgetti, M; Bosker, FJ; Hogg, S; Arnt, J; Mørk, A; Honig, G; Bøgesø, KP i dr.. (2004). „Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade”. Neuropsychopharmacology 29 (10): 1782–9. DOI:10.1038/sj.npp.1300474. PMID 15138437.
↑ Burghardt, NS; Bush, DE; McEwen, BS; Ledoux, JE (2007). „Acute SSRIs Increase Conditioned Fear Expression: Blockade with a 5-HT2C Receptor Antagonist”. Biological Psychiatry 62 (10): 1111–8. DOI:10.1016/j.biopsych.2006.11.023. PMC 2129095. PMID 17524369.
↑ Manvich, D. F.; Kimmel, H. L.; Cooper, D. A.; Howell, L. L. (2012). „The Serotonin 2C Receptor Antagonist SB 242084 Exhibits Abuse-Related Effects Typical of Stimulants in Squirrel Monkeys”. Journal of Pharmacology and Experimental Therapeutics. DOI:10.1124/jpet.112.195156. PMID 22685342.

Spoljašnje veze

	Portal Medicina
	Portal Hemija

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[4] Kennett, GA; Wood, MD; Bright, F; Trail, B; Riley, G; Holland, V; Avenell, KY; Stean, T i dr.. (1997). „SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist”. Neuropharmacology 36 (4–5): 609–20. DOI:10.1016/S0028-3908(97)00038-5. PMID 9225286.

[5] Martin, JR; Ballard, TM; Higgins, GA (2002). „Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety”. Pharmacology, Biochemistry, and Behavior 71 (4): 615–25. DOI:10.1016/S0091-3057(01)00713-4. PMID 11888553.

[6] Di Matteo, V; Di Giovanni, G; Di Mascio, M; Esposito, E (1999). „SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system”. Neuropharmacology 38 (8): 1195–205. DOI:10.1016/S0028-3908(99)00047-7. PMID 10462132.

[7] Navailles, S; De Deurwaerdère, P; Porras, G; Spampinato, U (2004). „In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum”. Neuropsychopharmacology 29 (2): 319–26. DOI:10.1038/sj.npp.1300329. PMID 14560323.

[8] Navailles, S; Moison, D; Ryczko, D; Spampinato, U (2006). „Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors”. Journal of Neurochemistry 99 (4): 1311–9. DOI:10.1111/j.1471-4159.2006.04188.x. PMID 17018023.

[9] Navailles, S; Moison, D; Cunningham, KA; Spampinato, U (2008). „Differential regulation of the mesoaccumbens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine”. Neuropsychopharmacology 33 (2): 237–46. DOI:10.1038/sj.npp.1301414. PMID 17429406.

[10] Leggio, GM; Cathala, A; Moison, D; Cunningham, KA; Piazza, PV; Spampinato, U (2009). „Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens”. Neuropharmacology 56 (2): 507–13. DOI:10.1016/j.neuropharm.2008.10.005. PMC 3130963. PMID 18977370.

[11] Cremers, TI; Giorgetti, M; Bosker, FJ; Hogg, S; Arnt, J; Mørk, A; Honig, G; Bøgesø, KP i dr.. (2004). „Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade”. Neuropsychopharmacology 29 (10): 1782–9. DOI:10.1038/sj.npp.1300474. PMID 15138437.

[12] Burghardt, NS; Bush, DE; McEwen, BS; Ledoux, JE (2007). „Acute SSRIs Increase Conditioned Fear Expression: Blockade with a 5-HT2C Receptor Antagonist”. Biological Psychiatry 62 (10): 1111–8. DOI:10.1016/j.biopsych.2006.11.023. PMC 2129095. PMID 17524369.

[13] Manvich, D. F.; Kimmel, H. L.; Cooper, D. A.; Howell, L. L. (2012). „The Serotonin 2C Receptor Antagonist SB 242084 Exhibits Abuse-Related Effects Typical of Stimulants in Squirrel Monkeys”. Journal of Pharmacology and Experimental Therapeutics. DOI:10.1124/jpet.112.195156. PMID 22685342.

[1]